Ann & Robert H Lurie Children's Hospital of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Ann & Robert H Lurie Children's Hospital of Chicago sits in the top decile of US sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count).
Ann & Robert H Lurie Children's Hospital of Chicago: 159 sponsored US clinical trials, 31 recruiting.
Ann & Robert H Lurie Children's Hospital of Chicago sponsors 159 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 5 of these trials are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Eosinophilic Esophagitis, with 6 trials.
Top-decile sponsor footprint
Ann & Robert H Lurie Children's Hospital of Chicago ranks in the top decile of sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 112 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
159 total, page 4 of 4
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
NCT00179894
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
NCT00179868
Study of Medication for Functional Abdominal Pain in Children
NCT00564525
A Phase I/II Study of the Photon Radiosurgery System
NCT00179907
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
NCT00179764
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
NCT00179881
WT1 for the Detection of Minimal Residual Disease
NCT00179829
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
NCT00179803
Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma
NCT00179920
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 16 |
| Phase 3 | 2 |
| Phase 4 | 3 |
What is open in the Ann & Robert H Lurie Children's Hospital of Chicago pipeline
31 recruiting of 159 indexed (19% open); 103 completed (65%).
Phase mix: 5 late (III/IV) vs 29 early (I/II) (early-phase heavy).
Top condition: Eosinophilic Esophagitis (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ann & Robert H Lurie Children's Hospital of Chicago: open-pipeline peers nationwide
Peers matched on 159 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 159 trials (± recruiting share)
- Galderma R&D · 158 trials · 4% recruiting
- Pfizer's Upjohn has merged with Mylan to form Viatris · 158 trials · 0% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- University of Texas Southwestern Medical Center · 19% recruiting · 837 trials
- The University of Texas Health Science Center, Houston · 20% recruiting · 732 trials
Related
What to do with this Ann & Robert H Lurie Children's Hospital of Chicago page
159 registered trials is a research-attention snapshot, not an endorsement of Ann & Robert H Lurie Children's Hospital of Chicago or any single study.
- 31 of Ann & Robert H Lurie Children's Hospital of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eosinophilic Esophagitis is the condition Ann & Robert H Lurie Children's Hospital of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Esophagitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ann & Robert H Lurie Children's Hospital of Chicago pipeline card: 159 registered trials from official public datasets.Report a data error.